Live Science on MSN
China's 'artificial sun' reactor shatters major fusion limit — a step closer to near-limitless clean energy
China's EAST nuclear fusion reactor has successfully kept plasma stable at extreme densities, passing a major fusion ...
Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...
Hosted on MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback